IE
KPRX icon

Israel Englander’s Kiora Pharmaceuticals KPRX Stock Holding History

Israel Englander’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Buy
+74,202
New +$186K ﹤0.01% 5328
2018
Q4 		– Sell
-8
Closed -$14K – 3964
2018
Q3 		$14K Buy
+8
New +$21.5K ﹤0.01% 3835
2016
Q3 		– Sell
-10
Closed -$140K – 3445
2016
Q2 		$140K Buy
+10
New +$174K ﹤0.01% 2970

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Israel Englander's KPRX Position: Q2 2026 in Review

Israel Englander opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 74,202 shares worth $195K. The stake represents ﹤0.01% of the portfolio and ranks #5328 among its holdings. This is a return to the name: Israel Englander previously reported a position in KPRX as recently as Q3 2018.

Israel Englander first reported a position in KPRX in Q2 2016 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Israel Englander held 74,202 shares of Kiora Pharmaceuticals worth $195K as of Q2 2026.
  • Kiora Pharmaceuticals was a new Israel Englander position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5328 holding.
  • Israel Englander first reported a position in Kiora Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.